Intraductal papillary mucinous neoplasms of the pancreas: An updated experience

Keyphrases

• Intraductal Papillary mucinous Neoplasm 100%
• Invasive Cancer 64%
• Adenoma 24%
• Resection 20%
• Carcinoma in Situ 16%
• 5-year Survival 12%
• Pancreatic Resection 12%
• Branch Duct 12%
• Neoplasms 8%
• Colloids 8%
• Anaplastic 8%
• Main Duct 8%
• Invasive Component 8%
• Pancreas 4%
• Recurrent Disease 4%
• Clinical Features 4%
• Tumor 4%
• Mucus Production 4%
• Lymph Node Metastasis 4%
• Improved Survival 4%
• Pancreaticoduodenectomy 4%
• Johns Hopkins Hospital 4%
• Distal Pancreatectomy 4%
• Overall Survival 4%
• Total Pancreatectomy 4%
• Author Experience 4%
• Dysplasia 4%
• Malignant Potential 4%
• Pancreatic Ductal Adenocarcinoma 4%
• Tumor-free 4%
• 2-year Survival 4%
• Metachronous 4%
• Intraductal 4%
• Invasive Intraductal Papillary mucinous Neoplasm 4%
• Surgical Margin 4%
• Lag Time 4%
• Cystic Tumors of the Pancreas 4%
• Long-term Surveillance 4%
• Colloid Carcinoma 4%
• Main Branch 4%
• Neoplasm Recurrence 4%
• Uncinate 4%
• Tubular Carcinoma 4%

Medicine and Dentistry

• Intraductal Papillary Mucinous Tumor 100%
• Tumor Invasion 61%
• Adenoma 23%
• Carcinoma in Situ 15%
• Neoplasm 11%
• Recurrent Disease 7%
• Malignant Neoplasm 3%
• Survival Rate 3%
• Mucin 3%
• Carcinoma 3%
• Clinical Feature 3%
• Pancreas Adenocarcinoma 3%
• Neck 3%
• Lymph Node Metastasis 3%
• Pancreaticoduodenectomy 3%
• Pancreatectomy 3%
• Distal Pancreatectomy 3%
• Surgical Margin 3%
• Overall Survival 3%
• Mucinous Carcinoma 3%
• Dysplasia 3%
• Cystic Neoplasm 3%
• Tumor 3%